PAA

0.00%

17.5¢ pharmaust limited

Ann: Leiden University Medical Centre Monepantel COVID-19 Testing, page-100

First 100 Last

Share
Profile

Follow
ThriftyClown

282 Posts.

370

11/01/21

17:42

Post #: 50091501
Share

Originally posted by kpax: ↑

Hi Thrifty Clown,

There is a paucity of information on Covid 19 type vaccines. This will change over the months whilst continued research on vaccine subjects becomes available. We shall see who has the best recognition of T cells ( memory cells ) whilst others may have an antigen response only.

The theory is that the “best “ ones include producing a synthetic gene that makes the body produce a viral antigen that binds to B cells ( B cells find the virus ) , the theory continues that this makes the immune system up to date in recognition of the virus. At present the innate immune system take time to recognise the virus, by that time, Covid 19 has multiplied many times. When the immune system is activated quickly our good friends the T cells especially the cytotoxic ones go to work rapidly as well.

An example is my brother who acquired Covid 19 on the Diamond Princess (Japan ) He was hospitalised with mild symptoms then he may have passed it on to his wife. He was cured, but somehow he became positive again ( I think from the wife, who survived) yet he had no symptoms this time due to his adaptive immunity kicking in. This was early herd immunity at work.

The difference between MPL and a vaccine is that a vaccine does not kill the virus, it helps the body kill it, whereas MPL and Ivermectin do. Covid 19 requires four stages to replicate G1/G2/M and GO. MPL interferes with the cell regulatory protein CDK2 . This stops the virus replicating at G2.

Ivermectin stops the replication at G1.

MPL due to the mTOR inhibition activates T cells as well as igM cells ( these bind to B cells ) plus MPL also activate additional B cells. Theory is that the more T cells that are activated the greater the velocity of activation of the adaptive immune system. The more B cells in the body the more the body can isolate the virus.

In relation to our immunity response over time , what is better a “very good” vaccine ( FDA allows a vaccine if it is at least 50% effective) or a very good cure ?
It’s probably the same, at the moment it’s educated guess work. We need a cure for the people who are ineligible for a vaccine or from a geographical perspective in that it may be difficult for “hill tribes” to be vaccinated, and or your regular anti vaxxers etc.

Expand

I have learnt much today. This is an excellent forum. Thanks to all contributors.

PAA Price at posting: 10.0¢ Sentiment: Buy Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

There are more pages in this discussion • 6 more messages in this thread...

First 100 Last

Add PAA (ASX) to my watchlist

(20min delay)
Last 17.5¢		Change 0.000(0.00%)		Mkt cap ! $85.12M

Open	High	Low	Value	Volume
18.0¢	18.0¢	17.0¢	$141.2K	801.7K

Buyers (Bids)

No.	Vol.	Price($)
11	537419	17.0¢

Sellers (Offers)

Price($)	Vol.	No.
18.0¢	140000	3

View Market Depth

No.	Vol.	Price($)
11	537419	0.170
5	157060	0.165
9	476304	0.160
6	336734	0.155
8	225333	0.150

Price($)	Vol.	No.
0.180	140000	3
0.185	427553	5
0.190	720215	6
0.195	752882	12
0.200	297726	10

Last trade - 16.10pm 06/09/2024 (20 minute delay)

PAA (ASX) Chart

Ann: Leiden University Medical Centre Monepantel COVID-19 Testing, page-100

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

Shekel Brainweigh investor presentation webinar – the future of retail automation

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Leiden University Medical Centre Monepantel COVID-19 Testing, page-100

Top Stories

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Red Mountain Mining: record gold prices, two projects, two greenstone belts

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

As Nvidia cools, we're looking to Aussie AI

Shekel Brainweigh investor presentation webinar – the future of retail automation

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News